Brief: HBM Holdings Says NMPA Ind Clearance For Hbm9378/Skb378
05/02/2025 06:06
Feb 5 (Reuters) - Hbm Holdings 2142.HK :
* NMPA IND CLEARANCE FOR HBM9378/SKB378 IN TREATMENT OF COPD
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study